Northwest Biotherapeutics NWBO
OTC NWBO
$0.15 -0.01 (-6.25%)
At close: Sep 28, 2026 · 4:00 PM EDT

Northwest Biotherapeutics (NWBO) Operating Margin (2010 - 2026)

Updated

Northwest Biotherapeutics (NWBO) recorded Operating Margin of -1438.04% in Q2 2026, up 9843.64 percentage points from -11281.68% a year earlier and up 768.44 percentage points from the prior quarter.

Analysis

Northwest Biotherapeutics (NWBO) Operating Margin (2010 - 2026) Analysis & Trends

On a TTM basis, Northwest Biotherapeutics' Operating Margin came in at -2316.11% as of Jun 30, 2026, up 3661.04 percentage points year-over-year; for FY2025, it was -4347.90%, up 464.55 percentage points from FY2024.

  • Annual Operating Margin has a five-year change of +2360.47 percentage points (FY2020 to FY2025).
  • Across earlier years, Operating Margin came in at -4812.45% in FY2024 (-1939.36 pp), -2873.08% in FY2023 (+1118.66 pp), -3991.74% in FY2022 (+1252.24 pp) and -5243.98% in FY2021 (+1464.39 pp).
  • The Q2 2026 figure is the highest quarterly Operating Margin since Q1 2020.
  • On a year-over-year basis, Operating Margin has increased for three consecutive quarters, with an average year-over-year change of +370.23 percentage points over the last eight quarters.
  • Peak year-over-year performance for Operating Margin in the last five years was a gain of 19294.13 percentage points in Q3 2021, against a drop of 7857.37 percentage points in Q2 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at -2206.48% (Q1 2026), -2009.52% (Q4 2025) and -7160.00% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Northwest Biotherapeutics 250.40 Mn 240.41 Mn - -1,438.04%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,438.04%
Mar 31, 2026 -2,206.48%
Dec 31, 2025 -2,009.52%
Sep 30, 2025 -7,160.00%
Jun 30, 2025 -11,281.68%
Mar 31, 2025 -4,616.27%
Dec 31, 2024 -8,008.23%
Sep 30, 2024 -4,145.94%
Jun 30, 2024 -3,424.31%
Mar 31, 2024 -5,543.66%
Dec 31, 2023 -3,402.70%
Sep 30, 2023 -3,405.17%
Jun 30, 2023 -6,754.73%
Mar 31, 2023 -1,473.18%
Dec 31, 2022 -3,044.89%
Sep 30, 2022 -7,581.55%
Jun 30, 2022 -4,423.27%
Mar 31, 2022 -3,048.64%
Sep 30, 2021 -2,871.14%
Jun 30, 2021 -2,982.45%
API Access

Northwest Biotherapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=NWBO&period=max&api_key=YOUR_API_KEY